McAdam LLC’s Boston Scientific BSX Stock Holding History

McAdam LLC’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$227K	Buy	+5,318	New	+$289K	0.01%	452
2026 Q1	–	Sell	-2,889	Closed	-$275K	–	452
2025 Q4	$275K	Sell	2,889 -78	-3%	-$7.65K	0.01%	339
2025 Q3	$290K	Buy	2,967 +563	+23%	+$58.3K	0.01%	311
2025 Q2	$258K	Buy	2,404 +123	+5%	+$12.4K	0.01%	321
2025 Q1	$230K	Sell	2,281 -1,435	-39%	-$144K	0.01%	303
2024 Q4	$332K	Buy	3,716 +199	+6%	+$17.5K	0.02%	262
2024 Q3	$295K	Buy	+3,517	New	+$277K	0.02%	259
2022 Q4	–	Sell	-5,966	Closed	-$231K	–	196
2022 Q3	$231K	Sell	5,966 -134	-2%	-$5.38K	0.03%	199
2022 Q2	$227K	Buy	+6,100	New	+$248K	0.02%	201
2018 Q4	–	Sell	-105	Closed	-$4K	–	130
2018 Q3	$4K	Hold	105	–	–	﹤0.01%	432
2018 Q2	$3K	Buy	+105	New	+$3.17K	﹤0.01%	447

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

McAdam LLC's BSX Position: Q2 2026 in Review

McAdam LLC opened a new position in Boston Scientific (BSX) in Q2 2026: 5,318 shares worth $227K. The stake represents 0.01% of the portfolio and ranks #452 among its holdings. This is a return to the name: McAdam LLC previously reported a position in BSX as recently as Q4 2025.

McAdam LLC first reported a position in BSX in Q2 2018 and has held it in 11 quarters since. The position peaked at $332K in Q4 2024. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

McAdam LLC held 5,318 shares of Boston Scientific worth $227K as of Q2 2026.
Boston Scientific was a new McAdam LLC position in Q2 2026.
Boston Scientific made up 0.01% of McAdam LLC's portfolio in Q2 2026, its #452 holding.
McAdam LLC first reported a position in Boston Scientific in Q2 2018 and has held it in 11 quarters since.
McAdam LLC's Boston Scientific position peaked at $332K in Q4 2024.
1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on McAdam LLC's 13F filing for Q2 2026, filed 4 Aug 2026.